Back to results
US 2026/0108487 A1Published application
Oral composition
AssigneeKao Corporation
InventorsYusuke KOBAYASHI, Yuichi SHIMODA
Life of this patent
Estimating the term…
Abstract
Provided is an oral composition, including the following components (A), (B), and (C): (A) 5 mass % to 20 mass % of a chlorogenic acid; (B) 0.001 mass % or more and less than 0.4 mass % of caffeine; and (C) 4-vinylguaiacol, wherein a mass ratio of the component (C) to the component (B), [(C)/(B)], is 3×10−4 or more and 1100×10−4 or less.
Claims18
An oral composition, comprising the following components (A), (B), and (C):
- (A) 5 mass % to 20 mass % of a chlorogenic acid;
- (B) 0.001 mass % to less than 0.4 mass % of caffeine;
- and
- (C) 4-vinylguaiacol,
- wherein a mass ratio of the component (C) to the component (B), [(C)/(B)], is from 3×10−4 to 1100×10−4.
2 more elements
A method of suppressing astringency of an oral product comprising 5 mass % to 20 mass % of (A) a chlorogenic acid and 0.001 mass % to less than 0.4 mass % of (B) caffeine, the method comprising:
- mixing (C) 4-vinylguaiacol with the oral product such that a mass ratio of (C) 4-vinylguaiacol to (B) caffeine, [(C)/(B)], of 3×104 to 1100×10−4 is obtained.
Dependencies are inferred from the claim text.